Table of Contents
Chemotherapy Research and Practice
Volume 2012 (2012), Article ID 351210, 10 pages
http://dx.doi.org/10.1155/2012/351210
Review Article

Dermatologic Toxicities from Monoclonal Antibodies and Tyrosine Kinase Inhibitors against EGFR: Pathophysiology and Management

Division of Oncology, Department of Medicine, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, New york, NY 10461, USA

Received 18 May 2012; Revised 24 July 2012; Accepted 24 July 2012

Academic Editor: Sue S. Yom

Copyright © 2012 Shaad E. Abdullah et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Shaad E. Abdullah, Missak Haigentz Jr., and Bilal Piperdi, “Dermatologic Toxicities from Monoclonal Antibodies and Tyrosine Kinase Inhibitors against EGFR: Pathophysiology and Management,” Chemotherapy Research and Practice, vol. 2012, Article ID 351210, 10 pages, 2012. doi:10.1155/2012/351210